Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

Nature Cell Biology

Volumn 6, Issue 11, 2004, Pages 1122-1128

  Jacinto, Estela ^a   Loewith, Robbie ^a   Schmidt, Anja ^b   Lin, Shuo ^a   Rüegg, Markus A ^a   Hall, Alan ^b   Hall, Michael N ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; PROTEIN KINASE; RAPAMYCIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOSKELETON; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; GENETIC CONSERVATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTINS; ANIMALS; CELL CYCLE PROTEINS; CELL LINE; CYTOSKELETON; HUMANS; MICE; NIH 3T3 CELLS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIROLIMUS;

EUKARYOTA; MAMMALIA; RAPTORES; SACCHAROMYCETALES; TOR;

EID: 7944235758     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1183     Document Type: Article

References (30)

1. Loewith, R. et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457-468 (2002).
2. Wedaman, K. P. et al. Tor kinases are in distinct membrane-associated protein complexes in Saccharomyces cerevisiae. Mol. Biol. Cell 14, 1204-1220 (2003).
3. Jacinto, E. & Hall, M. N. Tor signalling in bugs, brain and brawn. Nature Rev. Mol. Cell Biol. 4, 117-126 (2003).
4. Hara, K. et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189 (2002).
5. Kim, D. H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (2002).
6. Kim, D. H. et al. GβL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell 11, 895-904 (2003).
7. Harris, T. E. & Lawrence, J. C. TOR signaling. Sci. STKE 15, 1-17 (2003).
8. Gingras, A. C., Raught, B. & Sonenberg, N. mTOR signaling to translation. Curr. Top. Microbiol. Immunol. 279, 169-197 (2004).
9. Brunn, G. J. et al. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15, 5256-5267 (1996).
10. Sarkaria, J. N. et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59, 4375-4382 (1999).
11. Davies, S. P., Reddy, H., Caivano, M. & Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105 (2000).
12. Ridley, A. J. Growth factor-induced actin reorganization in Swiss 3T3 cells. Methods Enzymol. 256, 306-313 (1995).
13. Schaller, M. D. Paxillin: a focal adhesion-associated adaptor protein. Oncogene 20, 6459-6472 (2001).
14. Etienne-Manneville, S. & Hall, A. Rho GTPases in cell biology, Nature 420, 629-635 (2002).
15. Fingar, D. C. & Blenis, J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23, 3151-3171 (2004).
16. Xia, Y. et al. Mammalian target of rapamycin and protein kinase A signaling mediate the cardiac transcriptional response to glutamine. J. Biol. Chem. 278, 13143-13150 (2003).
17. Lamb, R. F. et al. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nature Cell Biol. 2, 281-287 (2000).
18. Astrinidis, A. et al. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. Oncogene 21, 8470-8476 (2002).
19. Schmidt, A., Bickle, M., Beck, T. & Hall, M. N. The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2. Cell 88, 531-542 (1997).
20. Chou, M. M. & Blenis, J. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85, 573-583 (1996).
21. Fang, Y. et al. PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1. Curr. Biol. 13, 2037-2044 (2003).
22. Peterson, R. T., Beal, P. A., Comb, M. J. & Schreiber, S. L. FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J. Biol. Chem. 275, 7416-7423 (2000).
23. Oshiro, N. et al. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes Cells 9, 359-366 (2004).
24. Dos, D. S. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302 (2004).
25. Hubberstey, A., Yu, G., Loewith, R., Lakusta, C. & Young, D. Mammalian CAP interacts with CAP, CAP2, and actin. J. Cell. Biochem. 61, 459-466 (1996).
26. Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D. & Hall, A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70, 401-410 (1992).
27. Dennis, P. B. et al. Mammalian TOR: a homeostatic ATP sensor. Science 294, 1102-1105 (2001).
28. Brummelkamp, T. R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
29. Azim, A. C., Barkalow, K. L. & Hartwig, J. H. Determination of GTP loading on Rac and Cdc42 in platelets and fibroblasts. Methods Enzymol. 325, 257-263 (2000).
30. Notredame, C., Higgins, D. G. & Heringa, J. T-Coffee: A novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 302, 205-217 (2000).